Simgibong CEO "Several New Products to Launch in Second Half... Entering Top 10 Global Implants Within 3 Years"
[Asia Economy Reporter Kum Boryeong] "In addition to implants, we have a diverse business portfolio, so we expect synergy effects."
Shim Gibong, CEO of Dentis, said in an interview with Asia Economy on the 28th, "There are already several new products scheduled for the second half of this year."
Founded in 2005, Dentis started with dental implants and now deals with medical surgical lights, digital clear aligners, dental 3D printers, and bio materials. Its dental implants, with a customer-friendly lineup, rank within the top 4 trusted domestic manufacturing brands, and its medical surgical lights hold the number one market share. Dentis products are exported to over 80 countries.
The diverse business portfolio is a strength of Dentis. CEO Shim explained, "We continuously conduct research and development (R&D) by taking on challenges that are essential to the dental industry but were not available domestically. A representative example is Dentis launching LED surgical lights in a market that previously relied on halogen lights and imports." He added, "Customers who purchase implants also become customers for surgical lights and 3D printers, creating sales synergy."
CEO Shim attributes Dentis's current status to steady R&D investment. With two research institutes and eight research teams, the company continuously develops new products while considering future growth opportunities. Dentis's intellectual property (IP) status includes 92 patent applications and 51 registrations. Based on these efforts, ultra-precise 4K LCD 3D printers and UV curing devices are scheduled for release in the second half of the year. Additionally, the company plans to start its digital clear aligner business within this year.
Shim said, "Due to the COVID-19 pandemic, the market became difficult, making it challenging to go public. However, the approval of the preliminary listing review despite uncertain circumstances demonstrates the company's resilience and acknowledges its sustainable growth." Dentis's performance last year recorded sales of 60.4 billion KRW and operating profit of 7.8 billion KRW. The recent three-year average growth rate was 13.2% annually, and since its establishment until last year, it showed an average annual growth of 25%.
He expressed his ambition, saying, "Within three years, we aim to become a top 10 global company in the implant sector." He added, "Based on fixture production volume, we seem to be already near the global top 10. We will lead greater growth based on stable performance."
Dentis will be listed on the KOSDAQ market through a merger with Hana Financial No.9 SPAC. The merger date is scheduled for the 12th of next month, and the new shares from the merger are expected to be listed on July 3rd. After listing, 40% of the merger funds will be invested in new businesses, 30% will be used for operating funds, and the remaining 30% will be allocated for facility investments such as equipment replacement.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
